Get the Stockscreener App
83.80
1.43%
-1.17
Transmedics Group Inc stock is traded at $83.80, with a volume of 545.32K.
It is down -1.43% in the last 24 hours and down -39.73% over the past month.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
See More
Previous Close:
$84.97
Open:
$84.7
24h Volume:
545.32K
Relative Volume:
0.42
Market Cap:
$2.83B
Revenue:
$358.76M
Net Income/Loss:
$3.00M
P/E Ratio:
-76.18
EPS:
-1.1
Net Cash Flow:
$-220.97M
1W Performance:
-5.36%
1M Performance:
-39.73%
6M Performance:
-34.56%
1Y Performance:
+96.52%
1-Day Range:
$82.60
$84.88
1-Week Range:
$79.90
$89.42
52-Week Range:
$40.01
$177.37
Transmedics Group Inc Stock (TMDX) Company Profile
Name
Transmedics Group Inc
Sector
Industry
Phone
(978) 552-0900
Address
200 MINUTEMAN ROAD, ANDOVER, MA
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Aug-02-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-08-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-07-20 | Initiated | Oppenheimer | Outperform |
| May-28-19 | Initiated | Canaccord Genuity | Buy |
| May-28-19 | Initiated | Cowen | Outperform |
| May-28-19 | Initiated | JP Morgan | Overweight |
| May-28-19 | Initiated | Morgan Stanley | Equal-Weight |
View All
Transmedics Group Inc Stock (TMDX) Latest News
(TMDX) Trading Signals - Stock Traders Daily
TransMedics Group, Inc. (NASDAQ:TMDX) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Sold by Emerald Advisers LLC - MarketBeat
These Analysts Cut Their Forecasts On TransMedics Group Following Weak Results - MSN
TMDX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - The Malaysian Reserve
3 Stocks Well Below 52-Week Highs With Strong Growth Projections - MarketBeat
16,308 Shares in TransMedics Group, Inc. (NASDAQ:TMDX) Acquired by State of Alaska Department of Revenue - MarketBeat
William Blair Has Negative Estimate for TMDX FY2024 Earnings - MarketBeat
TMDX INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - Business Wire
TransMedics Group (NASDAQ:TMDX) Sees Large Volume IncreaseTime to Buy? - MarketBeat
This Is What Whales Are Betting On TransMedics Gr - Benzinga
TransMedics (TMDX) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
What You Can Learn From TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S After Its 44% Share Price Crash - Simply Wall St
TransMedics: Maintaining A Neutral Stance After A Difficult Q3 (NASDAQ:TMDX) - Seeking Alpha
William Blair Predicts Higher Earnings for TransMedics Group - MarketBeat
TransMedics Group, Inc. (NASDAQ:TMDX) Q3 2024 Earnings Call Transcript - MSN
TransMedics Group Posts Weak Results, Joins Harmonic, Crocs, D.R. Horton And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - MSN
TransMedics Group (FRA:8T8) Owner Earnings per Share (TTM) : -2.02 (As of Sep. 2024) - GuruFocus.com
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - WV News
TransMedics: Every Hero Becomes A Bore At Last (NASDAQ:TMDX) - Seeking Alpha
Organ Transplant MedTech TransMedics Q3 Performance Disappoints, Analyst Outlines Investor Worries - Yahoo Finance
TransMedics Group (NASDAQ:TMDX) Earns Overweight Rating from Piper Sandler - MarketBeat
RSI Alert: TransMedics Group (TMDX) Now Oversold - Nasdaq
TransMedics Stock Falls as Q3 Earnings & Sales Miss Estimates - Zacks Investment Research
TransMedics Stock Dives 30% Despite Strong Revenue Growth: What’s Behind the Drop? - Financialbuzz.com
TransMedics Group (NASDAQ:TMDX) Shares Gap Down Following Weak Earnings - MarketBeat
TransMedics Group Inc (TMDX) Q3 2024 Earnings Call Highlights: Robust Revenue Growth Amid ... - Yahoo Finance UK
TransMedics Stock Crashes After Earnings Disappointment. Time to Load Up the Boat? - The Globe and Mail
TransMedics Group Inc (TMDX) Q3 2024 Earnings Call Highlights: Robust Revenue Growth Amid ... By GuruFocus - Investing.com Canada
TransMedics: Mistakes Have Been Made, Here's My Updated Outlook (NASDAQ:TMDX) - Seeking Alpha
TransMedics Group (NASDAQ:TMDX) Announces Earnings Results - MarketBeat
TransMedics stock target cut, Buy rating held amid revenue downturn By Investing.com - Investing.com UK
TransMedics Group Inc (TMDX) Q3 2024 Earnings Call Highlights: R - GuruFocus.com
TransMedics Stock Crashes After Earnings Disappointment. Time To Load Up The Boat? - Barchart
Earnings call: TransMedics reports robust Q3 growth with focus on expansion - Investing.com
TransMedics Group (NASDAQ:TMDX) Price Target Lowered to $109.00 at Needham & Company LLC - MarketBeat
TransMedics revenue jumps 64% to USD 108.8M in Q3 2024 - Medical Buyer
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Sold by J.W. Cole Advisors Inc. - MarketBeat
TransMedics: Q3 Earnings Snapshot - The Advocate
INVESTIGATION ALERT (NASDAQ:TMDX): DiCello Levitt LLP Is - GlobeNewswire
INVESTIGATION ALERT (NASDAQ:TMDX): DiCello Levitt LLP Is Investigating Investor Claims Against TransMedics Group, Inc. and Encourages TMDX Investors with Losses to Contact the Firm - GlobeNewswire Inc.
TransMedics Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
TransMedics (TMDX) Q3 Earnings and Revenues Miss Estimates - Yahoo Finance
TransMedics Group Stock Sinks On Q3 Earnings: The Details - Benzinga
TMDXTransMedics Group, Inc. Latest Stock News & Market Updates - StockTitan
Q3 2024 Transmedics Group Inc Earnings Call Transcript - GuruFocus.com
TransMedics Reports Third Quarter 2024 Financial Results - PR Newswire
Investors Purchase Large Volume of Call Options on TransMedics Group (NASDAQ:TMDX) - MarketBeat
TransMedics Group Inc (TMDX) Shares Up 5.11% on Oct 28 - GuruFocus.com
Transmedics Group Inc Stock (TMDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Transmedics Group Inc Stock (TMDX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hassanein Waleed H | President & CEO |
Oct 15 '24 |
Option Exercise |
13.28 |
8,625 |
114,540 |
70,268 |
| Hassanein Waleed H | President & CEO |
Oct 15 '24 |
Sale |
132.71 |
8,625 |
1,144,648 |
61,643 |
| Khayal Tamer I | Chief Commercial Officer |
Oct 01 '24 |
Option Exercise |
33.14 |
2,958 |
98,021 |
23,801 |
| Khayal Tamer I | Chief Commercial Officer |
Oct 01 '24 |
Sale |
148.24 |
2,958 |
438,491 |
20,843 |
| Hassanein Waleed H | President & CEO |
Sep 16 '24 |
Option Exercise |
13.28 |
8,625 |
114,540 |
70,268 |
| Hassanein Waleed H | President & CEO |
Sep 16 '24 |
Sale |
153.42 |
8,625 |
1,323,210 |
61,643 |
| Khayal Tamer I | Chief Commercial Officer |
Sep 03 '24 |
Option Exercise |
33.13 |
2,960 |
98,072 |
23,803 |
| Khayal Tamer I | Chief Commercial Officer |
Sep 03 '24 |
Sale |
159.60 |
2,960 |
472,404 |
20,843 |
| Corcoran Nicholas | See Remarks |
Aug 27 '24 |
Option Exercise |
69.83 |
10,000 |
698,318 |
31,105 |
| Corcoran Nicholas | See Remarks |
Aug 27 '24 |
Sale |
176.02 |
10,000 |
1,760,200 |
21,105 |
0.55%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):